Bei Cheng
Associate Principal Scientist AstraZeneca
Bei Cheng is an associate principal scientist at AstraZeneca’s Boston R&D center, having joined the company in 2022 after completing postdoctoral training at Johns Hopkins University in Baltimore. Within the advanced drug delivery organization at AstraZeneca, Bei specializes in the development of lipid nanoparticle formulations for new modalities and targeted gene delivery.
Seminars
Tuesday 21st July 2026
Expanding Therapeutic Reach Antibody-Conjugated Lipid Nanoparticles to Enhance Extrahepatic Nucleic Acid Delivery
2:30 pm
- Showcasing targeted LNP for enhanced bone marrow delivery: Multi-level biodistribution analysis
- Highlighting key formulation and ligand design principles that enable effective extrahepatic delivery beyond the liver
